← Back to Conditions

Hepatorenal syndrome

disorder
SNOMED 51292008CUI C0019212

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Clinical Trials

1
Total Trials
0
Recruiting
0
With Results

Recent Trials

Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis

NCT00359853Phase 4Completed70 enrolled
View all 1 trials on ClinicalTrials.gov

Research Evidence

Peer-reviewed studies linked via MeSH term "Syndrome, Hepatorenal" from the MEDLINE/PubMed database.

Sort:
Outcomes of Living-Donor Liver Transplant in Patients with Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.
[object Object], [object Object], [object Object] et al. · Exp Clin Transplant · 2025
PMID: 41118136Meta-Analysis
Terlipressin for the treatment of hepatorenal syndrome: a meta-analysis of randomized controlled trials.
[object Object], [object Object], [object Object] et al. · Eur J Gastroenterol Hepatol · 2025
PMID: 40207491Meta-Analysis
Incidence and type of adverse events in patients with cirrhosis receiving terlipressin: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Hepatol Commun · 2024
PMID: 39298544Meta-AnalysisFull text (PMC)
Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
[object Object], [object Object] · PLoS One · 2024
PMID: 38285703Meta-AnalysisFull text (PMC)
Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome.
[object Object], [object Object], [object Object] et al. · Cochrane Database Syst Rev · 2024
PMID: 38235907Meta-AnalysisFull text (PMC)
Spontaneous portosystemic shunts outside the esophago-gastric region: Prevalence, clinical characteristics, and impact on mortality in cirrhotic patients: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Eur J Intern Med · 2023
PMID: 36990875Meta-Analysis
The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis.
[object Object], [object Object], [object Object] et al. · Crit Care Med · 2022
PMID: 35777925Meta-Analysis
Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
[object Object], [object Object], [object Object] et al. · Dig Dis Sci · 2020
PMID: 31571102Meta-AnalysisFull text (PMC)
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
[object Object], [object Object], [object Object] et al. · Cochrane Database Syst Rev · 2019
PMID: 31513287Meta-AnalysisFull text (PMC)
Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Dig Liver Dis · 2018
PMID: 29422242Meta-Analysis
Search all PubMed articles for Hepatorenal syndrome

Research data from MEDLINE/PubMed

Related Conditions

Hepatorenal syndrome following delivery(child)
Hepatorenal syndrome due to a procedure(child)
Familial arthrogryposis-cholestatic hepatorenal syndrome(child)
HRS-AKI - hepatorenal syndrome-acute kidney injury(child)
Hepatic failure(parent)
Renal failure syndrome(parent)

Quick Facts

SNOMED CT
51292008
UMLS CUI
C0019212
Fully Specified Name
Hepatorenal syndrome (disorder)
Specialists
0
Diagnostic Biomarkers
0
Clinical Trials
1
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.